Abou-Taleb HA

ORCID: 0000-0001-7655-2088 · 3 papers in corpus
2024
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina60101676

Background and Objectives: Pregnant women face an increased risk of experiencing negative consequences due to COVID-19 infection. Our study aimed to identify outcomes for both mothers and fetuses associated with COVID-19 during each trimest…

article 2023
Applied immunohistochemistry & molecular morphology : AIMM ·doi:10.1097/pai.0000000000001148

BACKGROUND AND STUDY AIM: We aim to study the immunohistochemical expression of both hypoxia-inducible factor-1α (HIF-1α) and mammalian target of rapamycin (mTOR) in endometriosis to provide new evidence for a targeted endometriosis therapy…

2016
Oncotarget ·doi:10.18632/oncotarget.10181

Somatic mutations in the ARID1A tumor-suppressor gene have been frequently identified in ovarian clear cell carcinoma (CCC) cases. BAF250a encoded by ARID1A is a member of the SWI/SNF complex, but the expression and mutation status of other…